Project Grant HT94252410522
Award Date 7/1/24
Completion Date 6/30/26
Dollars Obligated $250K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Hamden, CT 06511, USA
Similar Awards
- This Project Grant award of $999,983.00 from the Defense Health Agency supports research by The Leland Stanford Junior University (Stanford University) to analyze Epstein-Barr virus (EBV) genomes, epigenomes, and EBV-dependent B cell proteomes. The goal is to identify fundamental viral triggers of multiple sclerosis (MS). The 3-year project will run from July 1, 2023 to June 30, 2026. This award is funded through the Military Medical Research and Development program (CFDA 12.420), which supports...
- The U.S. Defense Health Agency awarded a $250,000 Project Grant on July 1, 2023 to The Leland Stanford Junior University, also known as Stanford University, under the Military Medical Research and Development program (CFDA 12.420). The funding supports the isolation and engineering of potent anti-EBV neutralizing antibodies for the treatment of multiple sclerosis (MS). The project will be conducted at Stanford University's campus in Stanford, California over a 2-year period, ending on June 30,...
- This federal Project Grant award of $319,999.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of Maryland, Baltimore on the relationship between cortical lesions, meningeal inflammation, and Epstein-Barr virus infection in multiple sclerosis, as observed using 7-T MRI. The award period runs from November 1, 2024 to October 31, 2026. The research aims to advance understanding of the underlying...
- This $320,000 Project Grant award from the U.S. Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Ohio State University to create a mouse model for investigating how the Epstein-Barr virus (EBV) can reprogram and create pathogenic B cells, which is relevant to understanding the role of EBV in multiple sclerosis. The award period runs from September 1, 2025 to August 31, 2027. This research project aims to advance...
- The U.S. Defense Health Agency awarded a $999,006 Project Grant to The Wistar Institute of Anatomy and Biology in Philadelphia, PA under the Military Medical Research and Development program (CFDA 12.420). The grant, effective September 30, 2023 through September 29, 2026, will fund research on Epstein-Barr virus-driven B-cell inflammation and central nervous system trafficking in multiple sclerosis. The Wistar Institute has previously served as a subcontractor on federal grants, providing...
- This federal Project Grant award, valued at $999,999.00 and awarded by the Defense Health Agency, supports research under the Military Medical Research and Development program (CFDA 12.420) to investigate "EBV Signatures in Relapsing and Progressive Forms of MS" at Brigham & Women's Hospital, a subsidiary of Partners Healthcare System. This medical research grant will advance scientific understanding of the relationship between Epstein-Barr virus (EBV) and the development of...
- This $249,241 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the University of Queensland in Australia. The research aims to investigate how Epstein-Barr virus (EBV) infection at different ages impacts the development of central nervous system (CNS) demyelinating diseases using a novel humanized mouse model. The two-year project will be conducted from August 2024 to August 2026 to advance...
- This $250,000 Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research into TRNA-derived RNA fragments and their potential role in mediating multiple sclerosis associated with Epstein-Barr virus. The award, made on November 1, 2025, will support this research to be conducted by the University of Texas Medical Branch at Galveston over a one-year period, with a planned completion date of October 31,...
- The U.S. Department of Defense, through its Military Medical Research and Development program (CFDA 12.420), awarded a $460,279 Project Grant to Yale University on February 15, 2025. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research project, titled "LOSS OF PROTEOSTASIS AND VASCULAR AMYLOIDOSIS," focuses on investigating medical solutions for the battlefield and developing...
- The U.S. Defense Health Agency awarded a $1,213,276 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2023 through August 31, 2026, will fund research on the role of vascular mimicry in the outgrowth of dormant melanoma micrometastases. The goal of this research is to transform health care for Service Members and the American public through innovative and impactful medical research on solutions...